Report Detail
Global Molecular Theranostics Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4690115 |
- 27 April, 2026 |
- Global |
- 95 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Molecular Theranostics market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Molecular theranostics can be described as a system that integrates a diagnostic test with a therapeutic intervention targeting a molecular feature of disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Molecular Theranostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Molecular Theranostics market size and forecasts, in consumption value ($ Million), 2021-2032
Global Molecular Theranostics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Molecular Theranostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Molecular Theranostics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Molecular Theranostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Molecular Theranostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, BD, Biomerieux, Qiagen, Thermo Fisher Scientific, Agilent, GenMark, Siemens Healthcare, AutoGenomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Molecular Theranostics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Amplification Theranostics
Amplified Gene Detection Theranostics
Oligonucleotide Microarrays
Gene Sequencing
Market segment by Application
Hospitals and Clinics
Research Institutes
Diagnostic Centers
Others
Market segment by players, this report covers
Roche
Abbott
BD
Biomerieux
Qiagen
Thermo Fisher Scientific
Agilent
GenMark
Siemens Healthcare
AutoGenomics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Molecular Theranostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Molecular Theranostics, with revenue, gross margin, and global market share of Molecular Theranostics from 2021 to 2026.
Chapter 3, the Molecular Theranostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Molecular Theranostics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Theranostics.
Chapter 13, to describe Molecular Theranostics research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Molecular Theranostics by Type
- 1.3.1 Overview: Global Molecular Theranostics Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Molecular Theranostics Consumption Value Market Share by Type in 2025
- 1.3.3 Amplification Theranostics
- 1.3.4 Amplified Gene Detection Theranostics
- 1.3.5 Oligonucleotide Microarrays
- 1.3.6 Gene Sequencing
- 1.4 Global Molecular Theranostics Market by Application
- 1.4.1 Overview: Global Molecular Theranostics Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospitals and Clinics
- 1.4.3 Research Institutes
- 1.4.4 Diagnostic Centers
- 1.4.5 Others
- 1.5 Global Molecular Theranostics Market Size & Forecast
- 1.6 Global Molecular Theranostics Market Size and Forecast by Region
- 1.6.1 Global Molecular Theranostics Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Molecular Theranostics Market Size by Region, (2021-2032)
- 1.6.3 North America Molecular Theranostics Market Size and Prospect (2021-2032)
- 1.6.4 Europe Molecular Theranostics Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Molecular Theranostics Market Size and Prospect (2021-2032)
- 1.6.6 South America Molecular Theranostics Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Molecular Theranostics Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche Molecular Theranostics Product and Solutions
- 2.1.4 Roche Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Roche Recent Developments and Future Plans
- 2.2 Abbott
- 2.2.1 Abbott Details
- 2.2.2 Abbott Major Business
- 2.2.3 Abbott Molecular Theranostics Product and Solutions
- 2.2.4 Abbott Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Abbott Recent Developments and Future Plans
- 2.3 BD
- 2.3.1 BD Details
- 2.3.2 BD Major Business
- 2.3.3 BD Molecular Theranostics Product and Solutions
- 2.3.4 BD Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 BD Recent Developments and Future Plans
- 2.4 Biomerieux
- 2.4.1 Biomerieux Details
- 2.4.2 Biomerieux Major Business
- 2.4.3 Biomerieux Molecular Theranostics Product and Solutions
- 2.4.4 Biomerieux Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Biomerieux Recent Developments and Future Plans
- 2.5 Qiagen
- 2.5.1 Qiagen Details
- 2.5.2 Qiagen Major Business
- 2.5.3 Qiagen Molecular Theranostics Product and Solutions
- 2.5.4 Qiagen Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Qiagen Recent Developments and Future Plans
- 2.6 Thermo Fisher Scientific
- 2.6.1 Thermo Fisher Scientific Details
- 2.6.2 Thermo Fisher Scientific Major Business
- 2.6.3 Thermo Fisher Scientific Molecular Theranostics Product and Solutions
- 2.6.4 Thermo Fisher Scientific Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
- 2.7 Agilent
- 2.7.1 Agilent Details
- 2.7.2 Agilent Major Business
- 2.7.3 Agilent Molecular Theranostics Product and Solutions
- 2.7.4 Agilent Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Agilent Recent Developments and Future Plans
- 2.8 GenMark
- 2.8.1 GenMark Details
- 2.8.2 GenMark Major Business
- 2.8.3 GenMark Molecular Theranostics Product and Solutions
- 2.8.4 GenMark Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 GenMark Recent Developments and Future Plans
- 2.9 Siemens Healthcare
- 2.9.1 Siemens Healthcare Details
- 2.9.2 Siemens Healthcare Major Business
- 2.9.3 Siemens Healthcare Molecular Theranostics Product and Solutions
- 2.9.4 Siemens Healthcare Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Siemens Healthcare Recent Developments and Future Plans
- 2.10 AutoGenomics
- 2.10.1 AutoGenomics Details
- 2.10.2 AutoGenomics Major Business
- 2.10.3 AutoGenomics Molecular Theranostics Product and Solutions
- 2.10.4 AutoGenomics Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 AutoGenomics Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Molecular Theranostics Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Molecular Theranostics by Company Revenue
- 3.2.2 Top 3 Molecular Theranostics Players Market Share in 2025
- 3.2.3 Top 6 Molecular Theranostics Players Market Share in 2025
- 3.3 Molecular Theranostics Market: Overall Company Footprint Analysis
- 3.3.1 Molecular Theranostics Market: Region Footprint
- 3.3.2 Molecular Theranostics Market: Company Product Type Footprint
- 3.3.3 Molecular Theranostics Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Molecular Theranostics Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Molecular Theranostics Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Molecular Theranostics Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Molecular Theranostics Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Molecular Theranostics Consumption Value by Type (2021-2032)
- 6.2 North America Molecular Theranostics Market Size by Application (2021-2032)
- 6.3 North America Molecular Theranostics Market Size by Country
- 6.3.1 North America Molecular Theranostics Consumption Value by Country (2021-2032)
- 6.3.2 United States Molecular Theranostics Market Size and Forecast (2021-2032)
- 6.3.3 Canada Molecular Theranostics Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Molecular Theranostics Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Molecular Theranostics Consumption Value by Type (2021-2032)
- 7.2 Europe Molecular Theranostics Consumption Value by Application (2021-2032)
- 7.3 Europe Molecular Theranostics Market Size by Country
- 7.3.1 Europe Molecular Theranostics Consumption Value by Country (2021-2032)
- 7.3.2 Germany Molecular Theranostics Market Size and Forecast (2021-2032)
- 7.3.3 France Molecular Theranostics Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Molecular Theranostics Market Size and Forecast (2021-2032)
- 7.3.5 Russia Molecular Theranostics Market Size and Forecast (2021-2032)
- 7.3.6 Italy Molecular Theranostics Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Molecular Theranostics Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Molecular Theranostics Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Molecular Theranostics Market Size by Region
- 8.3.1 Asia-Pacific Molecular Theranostics Consumption Value by Region (2021-2032)
- 8.3.2 China Molecular Theranostics Market Size and Forecast (2021-2032)
- 8.3.3 Japan Molecular Theranostics Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Molecular Theranostics Market Size and Forecast (2021-2032)
- 8.3.5 India Molecular Theranostics Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Molecular Theranostics Market Size and Forecast (2021-2032)
- 8.3.7 Australia Molecular Theranostics Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Molecular Theranostics Consumption Value by Type (2021-2032)
- 9.2 South America Molecular Theranostics Consumption Value by Application (2021-2032)
- 9.3 South America Molecular Theranostics Market Size by Country
- 9.3.1 South America Molecular Theranostics Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Molecular Theranostics Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Molecular Theranostics Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Molecular Theranostics Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Molecular Theranostics Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Molecular Theranostics Market Size by Country
- 10.3.1 Middle East & Africa Molecular Theranostics Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Molecular Theranostics Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Molecular Theranostics Market Size and Forecast (2021-2032)
- 10.3.4 UAE Molecular Theranostics Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Molecular Theranostics Market Drivers
- 11.2 Molecular Theranostics Market Restraints
- 11.3 Molecular Theranostics Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Molecular Theranostics Industry Chain
- 12.2 Molecular Theranostics Upstream Analysis
- 12.3 Molecular Theranostics Midstream Analysis
- 12.4 Molecular Theranostics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Molecular Theranostics. Industry analysis & Market Report on Molecular Theranostics is a syndicated market report, published as Global Molecular Theranostics Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Molecular Theranostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
